Faculty

Institution

Unit

Venue

John C. Araujo

The University of Texas MD Anderson Cancer Center

Affiliations

Division Of Medical Oncology

The University of Texas MD Anderson Cancer Center

NoneJohn C. Araujo is currently serving as a Division Of Medical Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

John C. Araujo

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

oncology urology prostate cancer cancer care cancer research cancer treatment genitourinary cancers pharmacology radiation oncology prostatic disease clinical research medicinal research metastasis pharmacotherapy surgical oncology molecular cancer medicine tumor biology therapeutic targets oncogenes cancer cells anti-cancer agents cancer discovery jama oncology clinical trials cancer management cancer imaging cancer biology overall survival nuclear medicine endocrine-related cancers cellular therapy oncologic imaging cancer growth skeletal tumor burden immune checkpoint inhibitors cancer disparities radiation therapy clinical radiation oncology tumor targeting castration-resistant prostate cancer gynecologic oncology vascular biology bone research positron emission tomography therapeutic efficacy prognostic biomarkers metastatic prostate cancer phase ii study abiraterone acetate clinical outcomes drug trials randomized controlled trials treatment options clinical mycology cancer risk clinical evidence leukemia retrospective cohort studies cohort studies tumor heterogeneity sclerostin specific resistance benign prostatic hyperplasia urological research endocrine oncology cisplatin-based neoadjuvant chemotherapy anti-pd-l1 durvalumab bone-targeted therapy castration-resistant progression serum insulin phase ii trial high risk finite abiraterone acetate meta-analysis integrative high-throughput sequencing

Notable Scholarly Works

Notable Federal Grants

Collaborators

1057 Early Targeted Biologics Are Associated With Improved Clinical Outcomes in Immune-Related Myocarditis, Myositis, and Myasthenia Gravis. Regular and Young Investigator Award Abstracts (2025)

immunologymedicineinflammatory diseasesimmune-related myocarditisautoimmune diseasesimmunologic diseasesimproved clinical outcomesrheumatismmyositisimmune responsesclinical rheumatologyautoimmunitymyasthenia gravisimmunotherapyinflammation

Abstract 3123: Fracturing the Tumor-Bone Alliance in Metastatic Prostate Cancer With Ra-223. Cancer Research (2025)

Pablo SanchisAgustina SabaterJuan BizzottoGaston PascualNicolas AnselminoJiabin DongJun YangGaniraju ManyamBradley BroomZhongcheng ShiShixia HuangRocio SeniukEleonora DondossolaTeocharis PanaretakisJohn AraujoPeter ShepherdPatricia TroncosoNora NavoneChristopher J. LogothetisDaniel E. FrigoElba VazquezPaul CornGeraldine GueronEstefania Labanca

tumor-bone alliancecancer researchcancer biologyprostate cancermetastatic prostate cancer

High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors. Clinical Cancer Research (2025)

cancer managementradiation oncologycancer researchsurgical oncologyurologyoncologycancer treatmentjama oncologypathologyhigh-dose chemotherapy

Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis. European Urology Oncology (2025)

endocrine-related cancersmetastasiscancer carelymph node metastasisradiation oncologysurgical oncologyurologypharmacotherapyprostatic diseasegenitourinary cancersphase 2oncologycancer treatmentprostate cancer

Clinical Outcomes of Frontline Gemflp in Advanced Urachal and Non-Urachal Adenocarcinomas of the Urinary Tract: The MD Anderson Cancer Center (Mdacc) Experience.. Journal of Clinical Oncology (2024)

surgeryfrontline gemflpbladder cancercancer careclinical outcomescancer researchsurgical oncologyurologyurinary tractgenitourinary cancersurological researchoncologysurgical pathologyprostate cancer

Data From Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-Derived Xenograft (Mda Pca Pdx) Series. (2024)

radiation oncologymolecular cancerurologycancer genomicsprostatic diseasegenitourinary cancersoncologyprostate canceroncogenescancer cellsmda pca pdxtumor biologyintegrative molecular analyses

Doxorubicin, Paclitaxel, and Cisplatin (Atp) for Relapsed/Refractory Germ Cell Tumors. Clinical Genitourinary Cancer (2024)

Jenny J XiangMatthew T CampbellShi-Ming TuJohn AraujoYago NietoJohn K LinLianchun XiaoAmishi Y ShahJianbo Wang

treatment and preventioncancer researchcancer discoverygenitourinary cancersoncologycancer treatmentcancer biologycell biology

Octs-06 a Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases. Neuro-Oncology Advances (2024)

pharmacologymetastasisgliomasbrain tumor researchurologypharmacotherapygenitourinary cancersoncologykidney cancerneuro-oncologycancer treatment

Data From I Pcat-1 /I, a Long Noncoding Rna, Regulates Brca2 and Controls Homologous Recombination in Cancer. (2023)

John R. PrensnerWei ChenMatthew K. IyerQi CaoTeng MaSumin HanAnirban SahuRohit MalikKari Wilder-RomansNora NavoneChristopher J. LogothetisJohn C. AraujoLouis L. PistersAshutosh K. TewariChristine E. CanmanKaren E. KnudsenNaoki KitabayashiMark A. RubinFrancesca DemichelisTheodore S. LawrenceArul M. ChinnaiyanFelix Y. Feng

genome biologycarcinogenesisgene expressioncancer geneticsradiation oncologycancer researchmolecular cancergeneticscancer genomicslong noncoding rnalong non-coding rnamolecular biologyoncogenesrna biologycancer biologytumor biology

Data From Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer. (2023)

Ana M. AparicioAndrea L. HarzstarkPaul G. CornSijin WenJohn C. AraujoShi-Ming TuLance C. PagliaroJeri KimRandall E. MillikanCharles RyanNizar M. TannirAmado J. ZuritaPaul MathewWadih ArapPatricia TroncosoPeter F. ThallChristopher J. Logothetis

urologybiostatisticsclinical researchoncologyplatinum-based chemotherapycancer treatmentprostate cancer

1
2
3
4
5
13
10 / page

John C. Araujo

The University of Texas MD Anderson Cancer Center

Affiliations

Division Of Medical Oncology

The University of Texas MD Anderson Cancer Center

NoneJohn C. Araujo is currently serving as a Division Of Medical Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

John C. Araujo

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

1057 Early Targeted Biologics Are Associated With Improved Clinical Outcomes in Immune-Related Myocarditis, Myositis, and Myasthenia Gravis. Regular and Young Investigator Award Abstracts (2025)

Abstract 3123: Fracturing the Tumor-Bone Alliance in Metastatic Prostate Cancer With Ra-223. Cancer Research (2025)

tumor-bone alliancecancer researchcancer biologyprostate cancermetastatic prostate cancer

High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors. Clinical Cancer Research (2025)

cancer managementradiation oncologycancer researchsurgical oncologyurologyoncologycancer treatmentjama oncologypathologyhigh-dose chemotherapy

Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis. European Urology Oncology (2025)

surgeryfrontline gemflpbladder cancercancer careclinical outcomescancer researchsurgical oncologyurologyurinary tractgenitourinary cancersurological researchoncologysurgical pathologyprostate cancer

Data From Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-Derived Xenograft (Mda Pca Pdx) Series. (2024)

radiation oncologymolecular cancerurologycancer genomicsprostatic diseasegenitourinary cancersoncologyprostate canceroncogenescancer cellsmda pca pdxtumor biologyintegrative molecular analyses

Doxorubicin, Paclitaxel, and Cisplatin (Atp) for Relapsed/Refractory Germ Cell Tumors. Clinical Genitourinary Cancer (2024)

Jenny J XiangMatthew T CampbellShi-Ming TuJohn AraujoYago NietoJohn K LinLianchun XiaoAmishi Y ShahJianbo Wang

treatment and preventioncancer researchcancer discoverygenitourinary cancersoncologycancer treatmentcancer biologycell biology

Octs-06 a Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases. Neuro-Oncology Advances (2024)

pharmacologymetastasisgliomasbrain tumor researchurologypharmacotherapygenitourinary cancersoncologykidney cancerneuro-oncologycancer treatment

Data From I Pcat-1 /I, a Long Noncoding Rna, Regulates Brca2 and Controls Homologous Recombination in Cancer. (2023)

Data From Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer. (2023)

urologybiostatisticsclinical researchoncologyplatinum-based chemotherapycancer treatmentprostate cancer

1
2
3
4
5
13
10 / page